Atlas Trials

An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on Lung Cancer Patients

Clinical trial NCT07142057 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07142057
Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
LUNG CANCER
Start date
2025-09-01
Primary completion
2027-09-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.